ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,697Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 1454

$698K Total Retail Price of All Prescriptions

Rank: 230 out of 1454

710 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 710 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 710 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 13,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 784 666 1 6
POTASSIUM CHLORIDE 748 620 2 15
METOPROLOL TARTRATE 540 444 3 10
OMEPRAZOLE 522 383 4 3
SIMVASTATIN 512 409 5 1
AMLODIPINE BESYLATE 427 373 6 2
HYDROCODONE-ACETAMINOPHEN 413 269 S3 7 7
HYDROCHLOROTHIAZIDE 345 292 8 9
PRAVASTATIN SODIUM 316 267 9 12
LISINOPRIL 309 244 10 4
ATENOLOL 290 243 11 18
NIFEDIPINE ER 285 249 12 102
WARFARIN SODIUM 274 240 13 17
LEVOTHYROXINE SODIUM 264 246 14 5
PLAVIX 263 233 15 45
TRIAMTERENE-HCTZ 249 207 16 44
CLONIDINE HCL 241 229 17 49
DIGOXIN 227 198 18 70
CAPTOPRIL 223 174 19 270
GLIPIZIDE XL 216 180 20 85
INSULIN SYRINGE 193 141 21 97
METOPROLOL SUCCINATE 184 156 22 13
GLIPIZIDE 181 168 23 62
KLOR-CON M20 177 148 24 54
RANITIDINE HCL 175 162 25 43
ACETAMINOPHEN-CODEINE 164 125 S3 26 179
CYCLOBENZAPRINE HCL 164 79 R 26 59
CLOPIDOGREL 160 136 28 32
NIFEDIAC CC 155 135 29 246
ALLOPURINOL 150 135 30 28
AMLODIPINE BESYLATE-BENAZEPRIL 144 108 31 65
GLIMEPIRIDE 140 110 32 33
METFORMIN HCL 137 108 33 8
NEXIUM 137 106 33 23
SERTRALINE HCL 129 102 35 26
GABAPENTIN 123 114 36 16
LANSOPRAZOLE 116 107 37 140
HUMULIN N 115 103 38 302
ZETIA 107 106 39 69
ISOSORBIDE MONONITRATE ER 107 96 39 46
METHYLDOPA 106 93 R 41 399
ADVAIR DISKUS 105 73 42 47
COMBIVENT 105 82 42 115
NIFEDICAL XL 101 84 44 326
ATORVASTATIN CALCIUM 100 88 45 11
CEFUROXIME 96 75 46 150
SPIRONOLACTONE 93 48 47 63
PREDNISONE 92 74 48 36
CHLORTHALIDONE 87 65 49 109
DIOVAN 86 86 50 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 62 51 27
DONEPEZIL HCL 83 78 52 29
COUMADIN 77 64 53 119
PHENYTOIN SODIUM EXTENDED 76 41 54 138
VERAPAMIL ER 73 53 55 89
SYNTHROID 72 67 56 25
ZOLPIDEM TARTRATE 70 55 57 19
LANOXIN 69 68 58 242
LANTUS 68 47 59 51
LOSARTAN POTASSIUM 67 54 60 14
AMITRIPTYLINE HCL 66 51 R 61 71
GEMFIBROZIL 64 54 62 128
PROPRANOLOL HCL 64 58 62 129
LOVASTATIN 63 60 64 39
LOSARTAN-HYDROCHLOROTHIAZIDE 63 51 64 38
GLIPIZIDE ER 60 48 66 92
TRAMADOL HCL 60 41 66 20
HYDRALAZINE HCL 59 59 68 67
NOVOLIN N 58 35 69 261
DILANTIN 57 30 70 244
METHYLDOPA-HYDROCHLOROTHIAZIDE 57 41 R 10 70 453
COLCRYS 56 45 72 116
TAMSULOSIN HCL 56 48 72 34
ALENDRONATE SODIUM 55 55 74 35
NITROSTAT 55 46 74 208
PROMETHAZINE HCL 55 32 R 74 82
CARVEDILOL 54 49 77 24
DIOVAN HCT 52 41 78 75
METOCLOPRAMIDE HCL 52 40 78 121
METOLAZONE 51 42 80 216
PAROXETINE HCL 51 36 80 73
JANUVIA 50 32 82 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.